Subclinical hypothyroidism in childhood obesity and its correlation with lipoproteins.

##article.abstract##

Background/Objective: There is an ongoing debate regarding the influence of subclinical hypothyroidism on body mass index. The objectives of the study were (i) to determine whether levels of thyroid stimulating hormone (TSH) are elevated in obese children, (ii)to compare the serum levels of triiodothyronine (T3 ) and thyroxine (T4 ) in obese with non-obese and (iii) to examine the association of subclinical hypothyroidism with lipoproteins and body mass index.

Methods: Fifty six obese children/adolescent girls aged 10.5±4.3years, BMI 31.2±2.2kg/m2 and apparently healthy children aged 11.2±5.2 years, BMI 21.0±2.1kg/m2 were evaluated. Serum T3 , T4 and TSH were measured using ELECSYS 1010 autoanalyzer while serum triglyceride, total cholesterol, LDL cholesterol, HDL cholesterol and glucose were measured using enzyme catalyzed colorimetric techniques.

Results: Subclinical hypothyroidism was observed in 10.7% of obese subjects. Significantly increase levels of T3 (p<0.02), TSH (p<0.01) and all lipoprotein fractions (p<0.001) except HDL cholesterol which was lower (p<0.001) were observed in obese than control subjects. TSH and triglyceride correlated positively with body mass index.

Conclusion: Subclinical hypothyroidism was present in 10.7% of obese children. TSH and triglyceride correlated positively with body mass index in childhood/adolescent obesity. There is need for this group of subjects to be evaluated for thyroid hormones so that those requiring therapy can be diagnosed and treated.

Keywords: Obesity, subclinical hypothyroidism, thyroid hormones, body mass index,lipoproteins.

Résumé
Il y a un débat continue sur l’influence de l’hypothyroïdisme subclinique sur l’indexe de masse corporelle. Les objectifs de cette étude étaient (i) de déterminer si les taux de stimulants d’hormones thyroïdiens (TSH) sont élevés chez les enfants obeses, (ii) de comparaitre les taux d’hormones thyroïdiens dans le sérum thiiodothyronine (T3 ) et thyroxine (T4 ) chez les obeses et non obeses et (ii) d’examiner l’association de l’hypothyroïdisme subclinique avec lipoprotéines et l’indexe de masse corporelle. Cinquante six enfants et adolescent filles obeses âgées de 10.5±4.3ans, IPC 31.2±2.2kg/m2 et les enfants apparemment sain âgées 11.2±5.2 ans, IPC 21.0±2.1kg/m2 étaient évaluées. Les taux de sérum T3 , T4 et TSH étaient mesures en utilisant l’auto analyseur ELECSYS 1010 cependant les taux de sérum triglycéride, cholestérol total, LDL cholestérol, cholestérol HDL et glucose étaient mesurés utilisant les techniques de colorimétriques catalysés par des enzymes. Hypothyroïdisme subclinique était observé chez 10.7% des sujets obese. Les taux significatifs augmentaient T3 (p<0.02), TSH (p<0.01) et toutes les fractions de lipoprotéines (p<0.001) exception cholestérol HDL qui était faible (p<0.001) étaient observé chez les sujets obeses que les sujets sains. TSH et triglycéride corrélaient positivement avec l’indexe de masse corporelle en obésité infantile et à l’adolescence. L’hypothyroïdisme subclinique était présent chez 10.7% des enfants obeses. Il est nécessaire pour ces sujets d’évaluer les hormones thyroïdiennes afin que ceux malades puissent être diagnostiqués et traités.

Correspondence: Emokpae MA, Department of Medical Laboratory Science, University of Benin, Benin City, Nigeria. Email: biodunemokpae@yahoo.com

pdf (îngilîzî)

##submission.citations##

Manji N, Boelaert K, Sheppard MC, et al. Lacks of association between serum TSH or free T4 and body mass index in euthyroid subjects. Clin Endocrinol 2006;64: 125-128.

Krysiak R, Marek B, and Okopien B. Subclinical hypothyroidism. Wiad Lek 2008;61(4-6):139-145.

De Moraes CMM, Mancini MC, de Melo ME, et al. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y Gastric bypass. Obesity Surg 2005; 15:1291.

Schlienger JL, Vin Zio S, Grunenberg F, Luca F, and Goichot B. Is subclinical hypothyroidism a cardiovascular risk factor? Rev Med Interne 2008;27(12):927-931.

Jafar TH, Chaturvedi N, and Pappas G. Prevalence of overweight and obesity and their association with hypertension and diabetes mellitus in an Indo-Asian population. Canadian Med Ass J 2006;24:1071-1077.

Hu D, Gray RS, Jablonski KA, et al. Effects of obesity and body fat distribution on lipids and lipoproteins in non diabetic American Indians: the Strong Heart study. Obesity Res 2000; 8:411-421.

Nagila A, Bhatt M, Poudel B, et al. Thyroid stimulating Hormone and its correlation with lipid profile in the obese Nepalese population. J Clin Diagn Res 2008;2 :932-937.

Bastermir M, Akin F, Alkis E, and Kaptanoghi B. Obesity is associated with increased serum TSH level, independent of thyroid function. Swiss Med Wkly 2007; 137(29-30):431-434.

Ozen OG, Canon E, Bulent G, et al. A retrospective analysis of the relationship of thyroid function with obesity in a single centre obesity outpatient policlinic. European congress of Endocrinology, Endocrine Abstracts 2009;20:477

Bhowmick SK, Dasari G, Leven KL, and Rettig KR. The prevalence of elevated serum Thyroid stimulating hormone in childhood/Adolescent obesity and of autoimmune thyroid disease in a subgroup. J Nat Med Ass 2007;99 (7):773-776.

Friedewald WT, Levy RT and Frederickson DS. Estimation of concentrations of low density lipoprotein cholesterol in plasma without use of preparative centrifuge. Clin Chem 1972;18:499-502.

Shon HS, Jung ED, Kim SH, and Lee JH. Free T4 is negatively correlated with body mass index in euthroid women. Korean J intern Med 2008

Grandone A, Santoro N, Coppola F, Perrone L and del Gludice EM. Thyroid function derangement and childhood obesity: an Italian experience. BMC Endocrine Dis 2010;10:8.

Rodoni N,Aujesky D, Vittinghoff E, Cornuz J, and Bauer D.Subclinical hypothyroidism and the risk of coronary Heart disease: A meta analysis. Am J Med 2006;119(7):541-551.

Whitaker RC, Wright JA, Pepe MS, Seidel KD, and Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997;337:869-873.

Roberts CG and Ladenson PW. Hypothyroidism. Lancet 2004;363:793-803.

Radetti G, Kleon W, Buzi F, et al Thyroid function and structure are affected in childhood obesity. J Clin Endocrinol Metab 2008;93(12):4749-4754.

Douyon L, and Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone and cortisol secretion. Endocrinol Metab Clin North Am 2002;31:173-189.

Reinher T, and Andler W. Thyroid hormones before and after weight loss in obesity. Arch Dis child 2002;87:320-323.

Guo F,Bakal K, Minokoshi Y, and Hollenberg AN. Leptin signaling targets the thyrotropin releasing hormone gene promoter in vivo. Endocrinology 2004;145:2221-2227.

ConsidineRV, Sinha MK,Heiman ML,et al . Serum immunoreactive-leptin concentration in normal-weight and obese humans. N Engl Med 1996;334:292-295.

Pinkney JH, Goodrick SJ, Katz J, et al. Leptin and the pituitary-Thyroid axis: a comparative study in lean, obese,hypothyroid and hyperthyroid subjects. Clin Endocrinol(oxf) 1998;49:583-588.

Rosenbaum M, Murphy EM, Heymsfield SB, et al. Low dose leptin administration reverses effects of sustained weight reductions on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 2002;87:2391-2394.

Farooqi S, and O’Rahilly S. Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr 2009;89:980S-984S.

Tagliaferi M, Berselli ME, Calo G, et al. Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition and lipid profile. Obes Res 2001;9:196-201.

Das SC, Isichei UP, Otokwula AA, et al. Neonatal chemical hypothyroidism in Nigeria. Annals Trop Paediatr 2004; 24:237-241.

Kvtny J. Nuclear thyroxine receptors and cellular metabolism of thyroxine in obese subjects before and after fasting. Horm Res 1985; 21:60-65.

Mihaly E, Fekete C, Tatro JB, et al.. Hypophysiotropic thyrotropin releasing hormone synthesizing neurons in the human hypothalamus are innervated neuropeptide Y, agouti-related protein and alpha melanocyte-stimulating hormone. J Clin Endocrinol Metab 2000; 85: 2596-25603.

Reinehr T, de Sousa G and Andler W. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipid. J Clin Endocrinol Metab 2006; 91(8):3088-3091.